FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313894712> ?p ?o ?g. }

• W4313894712 endingPage "252.e8" @default.
• W4313894712 startingPage "252.e1" @default.
• W4313894712 abstract "This study aimed to evaluate the safety and efficacy of ultra-hypofractionated stereotactic body radiation therapy (SBRT) to prostate bed.Sixty-six prostate cancer patients treated with postoperative ultra-hypofractionated SBRT between 2018 and 2020 were retrospectively reviewed. All patients received a total dose of 35 Gy to prostate bed in 5 fractions. Biochemical complete response (BCR), biochemical failure (BF), acute and late toxicities were assessed.After a median follow-up of 24.2 months (range, 6.4-37.2), seven patients (10.6%) developed BF, and the 2-year freedom from BF (FFBF) rate was 88.4%. BCR was observed in 57 patients (86.4%). The 2-year FFBF in patients with pre-SBRT PSA value of <0.2 ng/mL was higher than those with pre-SBRT PSA of ≥0.2 ng/mL (100% vs. 81.4%; P = 0.04). The 2-year FFBF in patients with BCR was significantly higher than in those without BCR (94.5% vs. 58.3%; P < 0.001). In multivariate analysis, pre-SBRT PSA and post-SBRT PSA values were prognostic factors for FFBF (P = 0.009 and P = 0.01, respectively). Nine patients (13.6 %) developed acute and late grade 2 genitourinary (GU) toxicities. There was no acute or late grade ≥3 GU toxicity. Acute and late grade ≥2 gastrointestinal (GI) toxicity was observed in 9 (13.6%) and 2 (3%) patients, respectively.Postoperative ultra-fractionated SBRT showed no severe acute toxicity and late toxicity rates of about 15%, in addition to excellent biochemical control rates. Pre- and post-SBRT PSA levels may be a predictor of BCR in patients receiving post-operative ultra-fractionated SBRT." @default.
• W4313894712 created "2023-01-10" @default.
• W4313894712 creator A5020924279 @default.
• W4313894712 creator A5047548619 @default.
• W4313894712 creator A5067644558 @default.
• W4313894712 creator A5068249344 @default.
• W4313894712 creator A5072585635 @default.
• W4313894712 date "2023-05-01" @default.
• W4313894712 modified "2023-10-16" @default.
• W4313894712 title "Treatment outcomes of postoperative ultra-hypofractionated stereotactic body radiotherapy in prostate cancer" @default.
• W4313894712 cites W1970324515 @default.
• W4313894712 cites W1980601718 @default.
• W4313894712 cites W1983228790 @default.
• W4313894712 cites W1998994416 @default.
• W4313894712 cites W2036220888 @default.
• W4313894712 cites W2044268778 @default.
• W4313894712 cites W2054976917 @default.
• W4313894712 cites W2140754632 @default.
• W4313894712 cites W2152529149 @default.
• W4313894712 cites W2156306108 @default.
• W4313894712 cites W2156399381 @default.
• W4313894712 cites W2159790321 @default.
• W4313894712 cites W2161462871 @default.
• W4313894712 cites W2161565979 @default.
• W4313894712 cites W2278230463 @default.
• W4313894712 cites W2346061096 @default.
• W4313894712 cites W2431449819 @default.
• W4313894712 cites W2469515271 @default.
• W4313894712 cites W2510755861 @default.
• W4313894712 cites W2585109238 @default.
• W4313894712 cites W2587523334 @default.
• W4313894712 cites W2720170400 @default.
• W4313894712 cites W2791322512 @default.
• W4313894712 cites W2900752862 @default.
• W4313894712 cites W2915526116 @default.
• W4313894712 cites W2928985222 @default.
• W4313894712 cites W2980439634 @default.
• W4313894712 cites W2981066984 @default.
• W4313894712 cites W2981757696 @default.
• W4313894712 cites W2988253605 @default.
• W4313894712 cites W3003111479 @default.
• W4313894712 cites W3035795202 @default.
• W4313894712 cites W3087977689 @default.
• W4313894712 cites W3088359655 @default.
• W4313894712 cites W3128646645 @default.
• W4313894712 cites W3168815344 @default.
• W4313894712 doi "https://doi.org/10.1016/j.urolonc.2022.12.001" @default.
• W4313894712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36631368" @default.
• W4313894712 hasPublicationYear "2023" @default.
• W4313894712 type Work @default.
• W4313894712 citedByCount "2" @default.
• W4313894712 countsByYear W43138947122023 @default.
• W4313894712 crossrefType "journal-article" @default.
• W4313894712 hasAuthorship W4313894712A5020924279 @default.
• W4313894712 hasAuthorship W4313894712A5047548619 @default.
• W4313894712 hasAuthorship W4313894712A5067644558 @default.
• W4313894712 hasAuthorship W4313894712A5068249344 @default.
• W4313894712 hasAuthorship W4313894712A5072585635 @default.
• W4313894712 hasConcept C116263406 @default.
• W4313894712 hasConcept C121608353 @default.
• W4313894712 hasConcept C126322002 @default.
• W4313894712 hasConcept C126894567 @default.
• W4313894712 hasConcept C133507102 @default.
• W4313894712 hasConcept C2776235491 @default.
• W4313894712 hasConcept C2777008409 @default.
• W4313894712 hasConcept C2779466945 @default.
• W4313894712 hasConcept C2780192828 @default.
• W4313894712 hasConcept C2780387249 @default.
• W4313894712 hasConcept C29730261 @default.
• W4313894712 hasConcept C2989005 @default.
• W4313894712 hasConcept C509974204 @default.
• W4313894712 hasConcept C71924100 @default.
• W4313894712 hasConceptScore W4313894712C116263406 @default.
• W4313894712 hasConceptScore W4313894712C121608353 @default.
• W4313894712 hasConceptScore W4313894712C126322002 @default.
• W4313894712 hasConceptScore W4313894712C126894567 @default.
• W4313894712 hasConceptScore W4313894712C133507102 @default.
• W4313894712 hasConceptScore W4313894712C2776235491 @default.
• W4313894712 hasConceptScore W4313894712C2777008409 @default.
• W4313894712 hasConceptScore W4313894712C2779466945 @default.
• W4313894712 hasConceptScore W4313894712C2780192828 @default.
• W4313894712 hasConceptScore W4313894712C2780387249 @default.
• W4313894712 hasConceptScore W4313894712C29730261 @default.
• W4313894712 hasConceptScore W4313894712C2989005 @default.
• W4313894712 hasConceptScore W4313894712C509974204 @default.
• W4313894712 hasConceptScore W4313894712C71924100 @default.
• W4313894712 hasIssue "5" @default.
• W4313894712 hasLocation W43138947121 @default.
• W4313894712 hasLocation W43138947122 @default.
• W4313894712 hasOpenAccess W4313894712 @default.
• W4313894712 hasPrimaryLocation W43138947121 @default.
• W4313894712 hasRelatedWork W1979955543 @default.
• W4313894712 hasRelatedWork W1995770171 @default.
• W4313894712 hasRelatedWork W2092577047 @default.
• W4313894712 hasRelatedWork W2288665527 @default.
• W4313894712 hasRelatedWork W2293453490 @default.
• W4313894712 hasRelatedWork W2589116110 @default.
• W4313894712 hasRelatedWork W2796078932 @default.

• next